Rimegepant for sudden dizzy spells with migraine symptoms
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study tests a medication called rimegepant (a CGRP blocker) as a treatment for sudden dizziness attacks that come with migraine-like symptoms. If you have these kinds of dizzy spells, this trial may help find out if the drug can stop them quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your dizziness is moderate to severe, rated above 4 on a 10-point dizziness scale.
- You have had at least 3 similar dizzy spells before, and each attack lasted more than 2 hours.
- Your dizzy spells come with migraine-like symptoms such as headache, sensitivity to light or sound, nausea, visual changes, or a history of migraine in you or your family.
- Doctors have already checked you and ruled out other causes of your dizziness.
- You are not pregnant or breastfeeding, and you do not have serious heart, liver, kidney, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.
This study tests a medication called rimegepant to see if it quickly relieves vertigo and dizziness during a vestibular migraine attack. Vestibular migraine causes symptoms like spinning or imbalance, often with headache. If you have frequent, moderate-to-severe episodes, this treatment might offer relief.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This study tests if the medicine rimegepant is safe for people with migraine. You may be able to join if you have had migraine for at least a year, have 4–14 migraine days per month, and have not had good results with other migraine medicines called triptans.
Hear when a new Dizziness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.